Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

Iodine Nutrition Status and Clinical Characteristics of Thyroid Cancer

NCT06623500 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2012-01-01
Last updated
2024-10-02

Condition(s) studied

Thyroid Cancer

Investigational drug(s) / intervention(s)

Iodine excessIodine suitable

Iodine excess: Iodine excess areas: water iodine ≥100μg/L; or urinary iodine concentration (median urinary iodine levels in children aged 8-10 years old)≥300μg/L

Iodine suitable: Iodine suitable areas:water iodine ≥40μg/L and ≤100μg/L; or urinary iodine concentration(median urinary iodine levels in children aged 8-10 years old) 100-199μg/L.

Study summary

The effect of iodine nutritional status on thyroid cancer has been controversial for many years. We designed a prospective cohort study that recruiting patients in different iodine areas who underwent thyroid cancer surgery in branch hospitals from 2012 to 2019,and follow up their clinical outcomes. We aimed to analyse the relationship between regional iodine nutrition level and pathological types, clinical features, and prognosis of thyroid cancer.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: 1. Age range: 18\~65 years old, gender not limited; 2. Living in the selected region for at least 5 years; 3. Patients who underwent thyroid surgery at various research centers were pathologically diagnosed with thyroid cancer; 4. The clinical data (general information、surgical scope 、pathological report、utrasonic report, etc )of the case is complete. Exclusion Criteria: 1. Diagnosed as other types of cancer or thyroid metastatic cancer; 2. There are serious comorbidities such as heart, liver, and kidney diseases present; 3. Unable to follow up on prognostic information.

Primary outcome measure(s)

  • Number of participants with recurrence — from enrollment to the final follow-up at 5 years
    Recurrence: diagnosed as the same type of thyroid cancer again by pathology
  • Number of participants with distant metastasis — from enrollment to the final follow-up at 5 years
    Distant metastasis: Pathological confirmed thyroid cancer occurring outside the thyroid gland
  • All-cause mortality — from enrollment to the final follow-up at 5 years
    The ratio of the total number of deaths caused by various reasons during the research period to the number of participants

Trial sites (1)

FacilityCityRegionStatus
Shandong Provincial Hospital Jinan Shandong Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06623500 on ClinicalTrials.gov ↗ ← All trials in China